Pharmacokinetics, metabolism and excretion of the glycine antagonist GV150526A in rat and dog

Xenobiotica

Volumn 33, Issue 4, 2003, Pages 415-428

  Kajbaf, M ^a   Barnaby, R J ^a   Bottacini, M ^a   Bertolotti, L ^a   Ismail, I M ^b   Cholerton, T J ^a   Pellegatti, M ^a  

^a GSK   (Italy)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAVESTINEL; GLYCINE RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILIARY EXCRETION; BINDING SITE; CALCIUM TRANSPORT; CANNULATION; CELL DEATH; CONTROLLED STUDY; DOG; DRUG EXCRETION; DRUG METABOLISM; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSTSYNAPTIC INHIBITION; RAT;

ANIMALS; AREA UNDER CURVE; BILE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOGS; FEMALE; GLYCINE; GLYCINE AGENTS; HYDROLYSIS; INDOLES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MASS SPECTROMETRY; RATS; RATS, WISTAR; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT;

ANIMALIA; CANIS FAMILIARIS;

EID: 0038171249     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/0049825031000072469     Document Type: Article

References (17)

1. DI FABIO, R., CAPELLI, A. M., CONTI, N., CUGOLA, A., DONATI, D., FERIANI, A., GASTALDI, P., GAVIRAGHI, G., HEWKIN, C. T., MICHELI, F., MISSIO, A., MUGNAINI, M., PECUNIOSO, A., QUAGLIA, A. M., RATTI, E., ROSSI, L., TEDESCO, G., TRIST, D. G. and REGGIANI, A., 1997, Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site. Journal of Medicinal Chemistry, 40, 841-850.
2. DI FABIO, R., CUGOLA, A., DONATI, D., FERIANI, A., GAVIRAGHI, G., RATTI, E., TRIST, D. G and REGGIANI, A., 1998, Identification and pharmacological characterization of GV150526, a novel glycine antagonist as a potent neuroprotective agent, Drugs of the Future, 23, 61-69.
3. FAED, E. M., 1984, Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metabolism Reviews, 15, 1213-1249.
4. GAVIRAGHI, G., DI FABIO, R., CUGOLA, A., DONATI, D., FERIANI, A., RATTI, E., TRIST, D. G. and REGGIANI, A., 1997, Novel glycine antagonists as neuroprotective agents. In Proceedings of the XIVth International Symposium on Medicinal Chemistry (Amsterdam: Elsevier), 28, pp. 81-95.
5. GILISSEN, R. A. H., FERRARI, L., BARNABY, R. J. and KAJBAF, M., 2000, Human hepatic metabolism of a novel 2-carboxyindole glycine antagonist for stroke: in-vitro-in-vivo correlations. Xenobiotica, 30, 843-856.
6. HASEGAWA, J., SMITH, P. and BENET, L. Z., 1982, Apparent intramolecular acyl migration of zomepirac glucuronide. Drug Metabolism and Disposition, 10, 469-473.
7. HOKE, J. F., DYKER, A. G., BARNABY, R. J. and LEES, K. R., 2000, Pharmacokinetics of GV150526 following multiple dosing in patients with acute stroke. European Journal of Clinical Pharmacology, 5, 867-872.
8. IAVARONE, L., HOKE, J. F., BOTTACINI, M., BARNABY, R. J. and PRESTON, G. C., 1999, First time in human for GV19677: Interspecies scaling applied on dose selection. Journal of Clinical Pharmacology, 39, 560-566.
9. LENZ, E. M., GREATBANKS, D., WILSON, I., SPRAUL, M., HOFMANN, M., TROKE, J., LINDON, J. and NICHOLSON, J. K., 1996, Direct Characterisation of drug glucuronide isomers in human urine by HPLC-NMR. Analytical Chemistry, 68, 2832-2837.
10. MCGURK, K. A., REMMEL, R. P., HOSAGRAHARA, V. P., TOSH, D. and BURCHELL, B., 1996, Reactivity of mefenamic acid 1-0-acyl glucuronide with proteins in-vitro and ex-vivo. Drug Metabolism and Disposition, 24, 842-849.
11. QIU, Y., BURLINGAME, A. L. and BENET, L. Z., 1997, Mechanisms for covalent binding of benoxaprofen glucuronide to human serum albumin. Drug Metabolism and Disposition, 26, 246-256.
12. REGGIANI, A., 1997, Substituted indole-2-carboxylates as in vivo potent antagonists acting at the strychnine-insensitive glycine binding site. Journal of Medicinal Chemistry, 40, 841-850.
13. SALMON, M., FENSELAU, C., CUKIER, J. O. and ODELL, G. B., 1974, Rapid transesterification of bilirubin glucuronides in methanol. Life Sciences, 15, 2069-2078.
14. SIDELMANN, U. G., LENZ, E., SPRAUL, M., HOMANN, M., TROKE, J., SANDERSON, P. N., LINDON, J. C., WILSON, I. D. and NICHOLSON, J. K., 1996, 750 MHz HPLC-NMR spectroscopic studies on the separation and characterisation of the positional isomers of the glucuronides of dihydro oxodibenzoxepin acetic acid. Analytical Chemistry, 68, 106-110.
15. SPAHN-LANGGUTH, H. and BENET, L. Z., 1992, Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism. Drug Metabolism Reviews, 24, 5-48.
16. WANG, M. and DICKINSON, R. G., 1997, Disposition and covalent binding of diflunisal and diflunisal acyl glucuronide in the isolated perfused rat liver. Drug Metabolism and Disposition, 26, 98-104.
17. ZIVIN, J. A., 1997, Neurprotective therapies in stroke. Drugs, 54, 83-89.